Emerging roles for endocannabinoids in long‐term synaptic plasticity
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
British Journal of Pharmacology (2003) 140, 781–789. doi:10.1038/sj.bjp.0705466
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Synaptic Plasticity and Memory: An Evaluation of the Hypothesis
Martin, S. J., Grimwood, P. D., & Morris, R. G. M. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.649 · Cited by 2,794 · cited 2×
“These phenomena have been studied extensively, and there is a large literature examining the roles of LTP and LTD in various forms of learning and memory that occur in different brain regions (see Martin et al., 2000; Kemp & Bashir, 2001; Silva, 2003; for review).”
BackgroundThe endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728 · cited 8×
“Experiments testing the role of Ca2þ in LTDi of the BLA have not been reported.”
BackgroundInfluentialBrain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373 · cited 1×
“A recent, intriguing study indicates that a previously characterized monoglyceride lipase is responsible for degradation of 2-AG (Dinh et al., 2002).”
BackgroundKatona, I., Rancz, E. A., Acsády, L., Ledent, C., Mackie, K., Hájos, N., & Freund, T. F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09506.2001 · Cited by 668 · cited 6×
“Experiments testing the role of Ca2þ in LTDi of the BLA have not been reported.”
BackgroundInfluentialGABAB autoreceptors regulate the induction of LTP
Davies, C. H., Starkey, S. J., Pozza, M. F., & Collingridge, G. L. (1991) · Nature · doi:10.1038/349609a0 · Cited by 615 · cited 1×
“It is worth noting that Collingridge and co-workers reported that activation of GABAB receptors on presynaptic interneuron terminals promotes LTP through a similar disinhibitory action (Davies et al., 1991).”
BackgroundIt could be habit forming: drugs of abuse and striatal synaptic plasticity
Gerdeman, G. L., Partridge, J. G., Lupica, C. R., & Lovinger, D. M. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00065-1 · Cited by 480 · cited 2×
“Such an endocannabinoid involvement in addiction-related neural plasticity (Gerdeman et al., 2003) may indicate a therapeutic role for cannabinoid-based medicines in the treatment of certain addictions, as suggested by the ability of cannabinoid agonists and uptake blockers to mitigate symptoms of…”
BackgroundSelf-citationAzad, S. C., Eder, M., Marsicano, G., Lutz, B., Zieglgänsberger, W., & Rammes, G. (2003) · Learning & Memory · doi:10.1101/lm.53303 · Cited by 220 · cited 1×
“Thus, it remains inconclusive that the role of endocannabinoids in LTDi is as a retrograde messenger, but this is a tempting possibility given the presynaptic expression and function of CB1 receptors in the BLA (Katona et al., 2001; Azad et al., 2003).”
BackgroundVela, G., Ruiz-gayo, M., & Fuentes, J. A. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00032-2 · Cited by 118 · cited 1×
“…may indicate a therapeutic role for cannabinoid-based medicines in the treatment of certain addictions, as suggested by the ability of cannabinoid agonists and uptake blockers to mitigate symptoms of opiate withdrawal in rodents (Vela et al., 1995; Yamaguchi et al., 2001; Del Arco et al., 2002).”
BackgroundYamaguchi, T., Hagiwara, Y., Tanaka, H., Sugiura, T., Waku, K., Shoyama, Y., Watanabe, S., & Yamamoto, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02655-5 · Cited by 104 · cited 1×
“…may indicate a therapeutic role for cannabinoid-based medicines in the treatment of certain addictions, as suggested by the ability of cannabinoid agonists and uptake blockers to mitigate symptoms of opiate withdrawal in rodents (Vela et al., 1995; Yamaguchi et al., 2001; Del Arco et al., 2002).”
Background
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“…et al., 1997; Marsicano and Lutz, 1999; Gerdeman et al., 2002; reviewed in Alger, 2002; Robbe et al., 2002; Azad et al., 2003; Freund et al., 2003; Gerdeman and Lovinger, 2003; Piomelli, 2003; Mato et al., 2004), 2) modulation of immune responses and the release of inflammatory mediators by CB1,…”
BackgroundTaming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
ENDOCANNABINOID-MEDIATED SYNAPTIC PLASTICITY IN THE CNS
Chevaleyre, V., Takahashi, K. A., & Castillo, P. E. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112834 · Cited by 783
Dendritic Excitability and Synaptic Plasticity
Sjöström, P. J., Rancz, E. A., Roth, A., & Häusser, M. (2008) · Physiological Reviews · doi:10.1152/physrev.00016.2007 · Cited by 725
Metadata
- Authors
- Gerdeman, G. L., & Lovinger, D. M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2003-11
- Volume
- 140
- Issue
- 5
- Pages
- 781-789
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2025422724
- Cited by
- 143
- References
- 10
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.